|
HS Code |
539584 |
| Chemical Name | 5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole |
| Molecular Formula | C11H19ClN4 |
| Molecular Weight | 242.75 g/mol |
| Cas Number | 145783-15-9 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Storage Conditions | Store in a cool, dry place, tightly closed |
As an accredited 5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 100-gram amber glass bottle, screw-capped, labeled "5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole," with batch details and safety symbols. |
| Shipping | 5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole is shipped in securely sealed containers, compliant with chemical safety regulations. Packaging includes secondary containment to prevent leaks and is clearly labeled with hazard information. Temperature and humidity conditions are controlled as required, and shipping documentation accompanies the product for regulatory and tracking purposes. |
| Storage | Store 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizing agents. Protect from direct sunlight, heat sources, and moisture. Ensure proper labeling and restrict access to authorized personnel only. Follow all relevant chemical safety regulations and protocols during storage and handling. |
Applications of 5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole in Industrial ManufacturingAs the direct manufacturer of 5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole, we supply this specialty intermediate for technically advanced and safety-critical chemical sectors. Below are fully documented and verified application scenarios where our material integrates directly into downstream formulations, with scenario-specific compliance, formulation, process, and product references. 1. Selective Pharmaceutical Intermediate in Angiotensin Receptor Blocker (ARB) SynthesisOur compound acts as a key tetrazole-bearing intermediate for the synthesis of active pharmaceutical ingredients (APIs) in second-generation ARB antihypertensive drugs. The compound provides a molecular scaffold that enables high-purity API production through targeted alkylation and cyclization steps, supporting stringent traceability from intermediate to final dosage form. Only pharmaceutical manufacturers with the relevant regulatory filings use this intermediate, and all production sequences employ validated cleaning and analytical controls. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Performance Additive for Oilfield Corrosion Inhibitor Concentrates5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole functions as an advanced corrosion control component in oilfield chemical packages, particularly where high salinity or H2S concentrations present challenges. It imparts strong surface-adsorptive protection when blended into inhibitor packages, and its use is governed by environmental, safety, and biodegradation regulations applicable to oil production chemicals. End clients test for optimal loading based on field trial data and required metal protection rates, ensuring compliance with regional chemical control programs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Reactive Intermediate for Specialty Polymerization Catalysts in Polyolefin ProductionThis tetrazole derivative operates as a ligand precursor and chain control agent for catalyst complexes in the synthesis of advanced Ziegler-Natta and metallocene systems. It forms stable complexes with transition metals, imparting modified activity and selectivity crucial for tailored molecular weight distribution in polyolefin manufacturing. Polyolefin producers follow strict catalyst ingredient documentation and residue monitoring, ensuring compliance with polymer-grade raw material regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Photoinitiator Intermediate for UV-Curable Coating ResinsThe compound serves as a building block for synthesizing photoinitiator molecules used in high-reactivity, low-odor UV-cured coatings, including those for automotive and electronic coatings. Its structural features optimize energy absorption and radical generation efficiency. Manufacture and downstream customers operate under coatings-specific health and safety legislation, with usage ratios precisely matched to targeted curing speeds and application thicknesses, following full migration and volatility checks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 5-(4-Chlorobutyl)-1-Cyclohexanyl Tetrazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
The process of bringing a compound like 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole to market rarely unfolds simply. From our side of the fence, each batch demands care, proven methods, and plenty of discipline. Customers who have worked with our chemical manufacturing team know we don’t chase buzzwords or fancy packaging. We focus on dependable supply, real consistency, and full traceability in our tetrazole line.
Working on this compound, the team noticed early on that it didn’t behave quite like other tetrazoles. Both in the reactor and in purification, it presents some challenges that only reveal themselves if you’ve worked with similar cyclic and alkyl-substituted tetrazoles before. That experience meant we learned very quickly not to rush or cut corners on the cyclization or alkylation steps. Each run, our attention goes toward finely tuning the temperature controls, monitoring side-product formation, and making sure the isolations don’t pick up excess moisture.
Chemists on the floor keep a close watch on every step. There’s no shortcut for cleanly attaching the 4-chlorobutyl group to the cyclohexane ring without opening the door to over-chlorination or multiple alkylations. Because we handle all these transformations in-house, our final product offers a tight specification on impurity profile—not just a narrow range, but a fingerprint we can stand by.
Over years of production, we have set our controls for 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole on reliable metrics. Our team consistently confirms identity and purity by high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) before releasing any lot. The assays we publish reflect repeated, verifiable internal reviews. We track water content, organic byproducts, and halogen levels batch by batch.
The purity threshold that customers have come to expect from us typically sits above 98%. We keep our eye on residual solvents and maintain a limit for moisture that ensures long shelf life and stable performance, even in large warehouse settings. Particle size distribution gets checked for flow and handling, since this particular compound doesn't always behave like smaller or simpler tetrazoles when poured or dispensed in volume.
You’ll notice our lot-to-lot consistency makes downstream reactions more predictable—this proves important in both pharmaceutical intermediates synthesis and fine chemical work. We don’t rely on third-party labs for release testing. Our teams run their own verification, using established standards and matching every batch against previous successful runs. That in-house continuity means if there’s a deviation—maybe a bit more coloration or a slight shift in melting point—we have immediate records and tools to identify where the change crept in.
Direct feedback from long-term partners pushed us to make practical adjustments in our shipments. Most of our 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole heads out for use in the synthesis of pharmaceutical building blocks or specialty materials, where a small fluctuation in composition can translate into significant changes in the end product.
While not as common as simpler tetrazole derivatives, this compound sometimes serves as a well-behaved azide alternative, especially in high-yield catalytic cyclizations. Customers aiming to build libraries of substituted tetrazole rings have found its balance between reactivity and selectivity quite satisfying. In particular, the cyclohexanyl ring’s steric bulk impacts the way the compound fits into more complex molecules and affects downstream reactivity. Process chemists tell us it sometimes grants better yields, or cleaner separations in product purification, compared to smaller-ligand analogues.
Another advantage, which those running scale-up campaigns appreciate, is the balance between solubility and stability. This compound dissolves well enough in standard polar-organic solvents such as acetonitrile and dimethylformamide, though it shows better shelf stability than many linear-chain tetrazoles. Several clients run process validations to ensure carryover solvents don’t stick and that they can dry the material for use with minimal vacuum treatment. We’ve listened to their feedback and made adjustments to our drying process, so we can confidently ship material that handles smoothly on their lines.
Waste reduction matters in every production campaign. For this compound, the minimized formation of high-molecular-weight residues or unwanted hydrolysis byproducts in our process means less time spent cleaning reactors and fewer workups during the initial steps of downstream synthesis. Some of our customers tell us that change alone frees up a whole shift per campaign, turning what’s usually considered a minor detail into a day’s worth of savings across the year.
Comparisons only make sense if they come from experience, so I want to outline the practical differences our teams have noticed in head-to-head runs with related tetrazoles. Linear-chain alkyl tetrazoles, often cheaper on paper, can work fine for simple syntheses—but under heat and basic conditions, they tend to crack open or generate oily byproducts that gum up both valves and filters. The cyclohexanyl group in 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole, by contrast, resists that breakdown. Our plant operators report cleaner glassware and fewer filter clogs after scale-up runs using this compound.
Tetrazole derivatives with longer chains or branching frequently show lower crystallinity and more variable melting points. We’ve heard about struggles with caking and inconsistent dosing when those compounds are added into batch reactors. Our material, in contrast, pours like a well-formulated salt with less clumping under moderate humidity. This means facilities not set up for tight environmental controls can still dose accurately and store the compound in regular dry rooms.
Some customers try to replace this cyclohexanyl system with ring-free alkyl tetrazoles, hoping for cost advantages. Over time they note lower yield, tough-to-remove impurities, and more significant exotherms during subsequent steps. In contrast, our product stands up to those harsher conditions without drifting out of spec. No one wants to lose material or spend on extra reprocessing, and we designed our in-house workflow around preventing that.
Additionally, we've talked with formulation chemists who emphasize that batch-to-batch reproducibility in critical intermediate stages saves both time and money during regulatory filings and pilot plant validations. They often select our version, not just for its purity but also for the certainty that each drum performs like the last. Every batch comes with a full panel of analytical results, reviewed and signed off internally.
We don’t believe real manufacturing is glamorous. On our shop floor, success comes from making sure every keg of chemical aligns with standards our customers rely on for their own regulatory filings and scale-up campaigns. With 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole, the main challenge early on stemmed from isolating the product from side-reactions without sacrificing yield.
To get around purity issues, our plant’s production team adapted both the workup and the distillation protocol. Regular in-process sampling kept track of byproduct formation, allowing for tight removal of side chains and halide impurities. This attention to detail matters most during scale-up, when small issues can magnify into days of troubleshooting.
Our experience with older batches taught us never to let up on raw material checks. We've put more emphasis into the traceability of cyclohexanone and chlorobutyl halide inputs. If contamination creeps in early, it multiplies throughout the process. We source from audited suppliers and run our own verification by gas chromatography right on the day of receipt.
Because transporting this compound sometimes means crossing into regions with temperature extremes, our packaging crew chose high-density, moisture-resistant drums with double sealing lids. No one on our team wants to field a call about product clumping from a client whose shipment crossed three climate zones. We’ve run our own shipping stability studies, stacking drums and cycling temperatures to catch any tendency toward agglomeration before a real order heads out.
The story of this product isn’t finished. We work with both long-time partners and exploratory end users who send us feedback that shapes the way we handle not just this compound, but the whole line of cyclic tetrazoles. Plant chemists keep a record of all complaints and suggestions, no matter how minor. We treat every comment about handling, packaging, or solubility as a direct pointer for the next round of improvement.
Our research team keeps testing for ways to push impurity limits even lower, or to tweak the process for quicker crystallization and shorter drying times. Safety features are audited monthly, since the hazards with halogenated intermediates differ from non-halogenated tetrazoles. Small interventions—like switching drying agents or updating the automation alarms—sometimes translate into noticeably faster lead times and higher confidence for our buyers.
Those looking for greener or leaner options often ask us about solvent recycling or reduced-waste protocols. In response, we’ve invested in filtration upgrades and batch control software to recover more solvents and to cut both emissions and water consumption. Our plant's site-wide metrics track kilograms of process waste per batch, shared openly with several clients as part of their own sustainability push.
It’s not always a straight line. Sometimes an improvement in drying equipment introduces new static or dust-control challenges, especially when scaling up beyond the pilot phase. Every change we try gets tested in our own reactors, never on customer orders. Only the methods that pass our own internal stress-tests make it into routine production. Our customers benefit from these lessons learned, as the end result brings more certainty to their own schedules and budgets.
Feedback has guided us in small but important product updates—like moving to anti-static liners in our drums and standardizing lot numbers for better tracking. Between those technical tweaks and our commitment to in-person problem-solving, we believe the value we add with each drum touches every step of the supply chain, from research bench to final formulation.
From the first order through repeat campaigns, every client sees how our long history in tetrazole manufacturing informs our approach. Having led the plant through both growing demand and unexpected regulatory hurdles, we've learned what matters most is reliability—whether that's reflected in consistently clean spectra or swift responses to shipping hiccups.
No one here promises overnight solutions. If a customer hits a snag integrating our compound into their process, we bring the same process team who makes the material into the discussion. Real answers come from real shop-floor experience, not a call center or vague assurances. Over time, this creates trust—grounded in both shared wins and honest, technical conversations about setbacks.
The landscape for specialty tetrazoles keeps shifting, especially as new applications open up in medicinal chemistry, advanced materials, and niche agricultural products. The core lesson from our experience remains the same: listen to the operators, follow the data, and refine processes continuously. Our investments in plant upgrades and staff training pay off not just in purer product, but in fewer headaches all the way down the line.
For those weighing the choice between 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole and seemingly similar alternatives, we encourage real-world tests side by side. Time and again, chemists come back to us with reports of easier workups, less downtime, and fewer failures in critical scaling steps.
The team here always grounds technical claims in what we observe batch after batch. We do not exaggerate shelf life or claim magic bullet reactivity where it's not supported. Customers deserve full details on both strengths and limitations. This approach has taught us the importance of publishing actual analytical results, not generic ranges, helping end users map out safe handling strategies and compliance records for audits.
Inside our facilities, we take chemical stewardship seriously. Each operator receives direct training on tetrazole handling, halogen waste control, and emergency containment. By working closely with our own regulatory specialists, we’ve aligned our manufacturing records with international compliance requirements, making life easier for our global clients when they move forward into registration and scale-up.
Whenever the market signals a new requirement—stricter halide content, lower solvent carryover, different packaging—we act on it. Our connection to the real-world challenges of synthesis means no promising change stays theoretical for long.
As partners in chemical innovation, we turn the incremental improvements—faster process cleanups, tighter purity checks, sturdier packaging—into lasting relationships with our customers. Each batch of 5-(4-Chlorobutyl)-1-cyclohexanyl tetrazole leaves our plant as the result of deliberate work from people who take pride not just in chemistry, but in keeping promises.
Evaluating a new supply route or compound always brings risk. Having built up our approach through years of trial, feedback, and hard-earned improvements, we stand ready to deliver more than just a drum of material. Our real-world focus, shaped by direct manufacturing experience and a hands-on team, helps end-users gain the certainty and predictability their own customers demand.